Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

502.12
Delayed Data
As of Jun 27
 -13.79 / -2.67%
Today’s Change
325.35
Today|||52-Week Range
543.55
+36.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash646.5M920.4M535.2M811.8M
 
 
 
 
 
Short Term Investment Cash42.3M273.9M-385.2M276.6M
 
 
 
 
 
Cash & Short Term Investments1.0B1.4B1.0B1.3B
 
 
 
 
 
 
ReceivablesReceivables1.8B1.6B1.6B1.7B
 
 
 
 
 
 
InventoriesInventories316.1M345.6M399.4M466.6M
 
 
 
 
 
 
Current AssetsOther Current Assets96.0M103.8M130.5M146.1M
 
 
 
 
 
Current Assets3.2B3.5B3.2B3.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----2.5B--
 
 
Depreciation-----425.5M--
 
 
Other Assets6.7M20.7M20.3M37.1M
 
 
 
 
 
Total Assets6.2B6.8B7.0B7.8B
 
 
 
 
 
 
LiabilitiesAccounts Payable101.7M124.5M135.0M141.8M
 
 
 
 
 
Short Term Debt0.000.00127.3M7.2M
 
 
 
Accrued Expenses373.1M295.2M355.3M375.1M
 
 
 
 
 
Other Current Liabilities565.0M541.5M590.4M614.4M
 
 
 
 
 
Other Liabilities951.6M961.2M1.2B1.3B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt361.5M382.2M351.6M700.4M
 
 
 
 
 
Deferred Taxes-626.2M-655.6M-825.3M-866.3M
 
 
 
 
 
Other Liabilities119.5M135.7M100.4M106.2M
 
 
 
 
 
Total Liabilities2.1B2.3B2.5B3.0B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity4.1B4.5B4.4B4.9B
 
 
 
 
 
Total Shareholder Equity4.1B4.5B4.4B4.9B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding105.3M105.5M106.0M106.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.